About Eckard Weber, M.D.
Form D filings for Transposon Therapeutics in 2020 list Eckard Weber, M.D. as executive officer and director.
Form D filings also name Eckard Weber, M.D. as a president and chief executive officer at Abrexa Pharmaceuticals and sits on its board.
Eckard Weber, M.D. first appears on SEC filings in 2011.
Experience
This experience comes from SEC filings. The years are when the filings name Eckard Weber, M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Eckard Weber, M.D. works with at each company, as listed on that company's latest Form D.
Transposon Therapeutics, Inc. · Form D, Dec 9, 2020
DP
Dennis Podlesak
Executive officer and director
JP
John Pacifico
Director
BA
Brent Ahrens
Director
LR
Lynne Rollins
Chief Financial Officer
Abrexa Pharmaceuticals, Inc. · Form D, Sep 6, 2011
LR
Lynne Rollins
Executive officer
NV
Nicole Vitullo
Director